Graft Polymer (GPL) Share Price, News & Analysis

Company Overview

Graft Polymer (UK) Plc is an innovative biotechnology company focused on developing intellectual property relating to the treatment of mental health and substance use disorders, and co-developing therapeutics for mental health disorders. Our mission is to improve outcomes for individuals suffering from these conditions, with an initial focus on trauma-related mental health disorders, such as PTSD, which affects approximately 13 million adults in the U.S. and 20 million in US, UK, and key EU markets.

Key Stats

• Today's Range: N/A
• 50-Day Range: 0.16 to 0.24
• 52-Week Range: N/A
• Volume: 4.15 million shs
• Average Volume: 8.69 million shs
• Market Capitalization: £3.79 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

GPL Stock Analysis - Frequently Asked Questions

How do I buy shares of Graft Polymer?

Shares of GPL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Industrials
• Industry: Specialty Industrial Machinery
• Sub-Industry: N/A
• Current Symbol: LON:GPL
• CIK: N/A
• Web: www.graftpolymer.com
• Phone: 44 20 4524 9900
• Fax: N/A
• Employees: 7
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (2.49)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-58,517,233.04
• Net Margins: -755.04%
• Pretax Margin: N/A
• Return on Equity: -142.35%
• Return on Assets: -38.87%

Debt

• Debt-to-Equity Ratio: 15.95
• Current Ratio: 0.15
• Quick Ratio: 18.19

Sales & Book Value

• Annual Sales: £7.75 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 5.09
• Book Value: GBX 1.59 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 2,324,101,227
• Free Float: N/A
• Market Cap: £3.79 million
• Optionable: Not Optionable
• Beta: 1.92